Seltorexant

sleep · nervous · Oral

Seltorexant, a sleep compound. Selective orexin-2 receptor antagonist investigated in clinical trials for insomnia and as adjunctive treatment for depression.

Selective orexin-2 receptor antagonist investigated in clinical trials for insomnia and as adjunctive treatment for depression.

PK: Conference-poster parameters were withdrawn under the PMID-only source policy. PMID:34324636 and PMID:40802194 remain cited clinical research; no replacement PK scalar is inferred from them. MASS: PubChem CID 86278359, free compound, molecular weight 407.4 g/mol; salt forms may differ. DOSE: PMID:40802194 studied oral doses of 5, 10, and 20 mg nightly for 14 days in adults with insomnia. These are trial arms, not a general dose recommendation.

Sources: PMID:40802194, PMID:34324636